Safinamide: an add-on treatment for managing Parkinson's disease.

about

Safinamide: an add-on treatment for managing Parkinson's disease.

Item

http://www.wikidata.org/entity/Q52804779

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Safinamide: an add-on treatment for managing Parkinson's disease.

@en

Safinamide: an add-on treatment for managing Parkinson's disease.

@nl

type

Item

label

Safinamide: an add-on treatment for managing Parkinson's disease.

@en

Safinamide: an add-on treatment for managing Parkinson's disease.

@nl

prefLabel

Safinamide: an add-on treatment for managing Parkinson's disease.

@en

Safinamide: an add-on treatment for managing Parkinson's disease.

@nl

P1476

Safinamide: an add-on treatment for managing Parkinson's disease.

@en

P2093

Thomas Müller

http://www.w3.org/2001/XMLSchema#string

P2860

The pharmacology of selegiline

Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder

Amantadine for levodopa-induced dyskinesias: a 1-year follow-up study

Tolcapone: a potential new antidepressant detected in a novel animal model of depression.

Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field.

Effects of ketoconazole treatment on the pharmacokinetics of safinamide and its plasma metabolites in healthy adult subjects.

The PRIPS study: screening battery for subjects at risk for Parkinson's disease.

Diagnostic criteria for Parkinson disease.

Tolcapone improves cognition and cortical information processing in normal human subjects.

Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005).

P304

31-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CPAA.S137740

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29670409

http://www.w3.org/2001/XMLSchema#string

P932

5896660

http://www.w3.org/2001/XMLSchema#string